Molecule intelOpportunity: StrongEssential

Penicillamine

9 brands · 5 companies · product forms

ATC: M01CC01

Opportunity snapshot

Launch attractiveness
54
Market saturation
14
Price room
88
Regulatory risk
0
9
brands
5
companies
Rs 859.8
median price
9
price points
4.51x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 33%

Price room

Across observed sources and strengths
CheapestRs 232.22
MedianRs 859.8
Most expensiveRs 1,048.09
Spread4.51×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.51x across 9 trusted points (Rs 232.22-1048.09). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 5 live products for Penicillamine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(37) + 25% price-variation(88) + 20% low-competition(86) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

5 canonical companies and 9 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.51x across 9 trusted points (Rs 232.22-1048.09). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.